21st Austria weekly - Valneva Andritz 16/05/2022 [pic1]Valneva: an Austrian/French specialty vaccine company announced that it has received a notice from the European Commission EC of intent to terminate advance purchase agreement APA for Valneva’s inactivated whole-virus COVID-19 candidate VLA2001. The APA provides EC with right if VLA2001 had not marketing authorization Medicines Agency